A Randomized, Double-blind Study Evaluating the Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor and Its Active Metabolite (AR-C124910XX) in Patients With ST-segment Elevation Myocardial Infarction and Non-ST-segment Elevation Myocardial Infarction
Phase of Trial: Phase IV
Latest Information Update: 29 Mar 2017
At a glance
- Drugs Ticagrelor (Primary) ; Morphine
- Indications Myocardial infarction
- Focus Pharmacokinetics
- Acronyms IMPRESSION
- 21 Oct 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Oct 2015 Results (n=70) published in the European Heart Journal
- 01 Jan 2015 Trial design presented at Trials.